Riskpilot← Back to searchSign inGet full accessSICCONA AB
ABActiveOrg 5564056421Igelösa 373Research and experimental development on natural sciences and engineering · NACE 7210Est. 19900 employees
Revenue 2024
SEK 0
EBITDA margin
—
-634% vs 2023
Equity ratio
81.5%
Financial strength
Net profit 2024
SEK 464K
+180% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -235K | -634% |
| Net profit | SEK 464K | +180% |
| Total assets | SEK 13,2M | -1% |
| Equity | SEK 10,8M | +5% |
| Employees | 0 | — |
Legal name
SICCONA AB
Org number
5564056421
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11 september 1990
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva forskning kring livstilsförändring med betoning på kost, motion, stressreduktion och sömn. Bolaget ska bedriva produktutveckling, vetenskaplig dokumentation kring hälsoprodukter samt därmed förenlig verksamhet.
Address
Igelösa 373
Phone
+4640480018
Email
martin.jansson@bjsv.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 1 800 | 17 173 | 4 730 | 989 | 260 | 105 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 51 | 255 | 205 | 65 | 14 184 | 989 | −668 | −71 | 44 | −235 |
| Depreciation & amort. | −52 | −40 | −26 | −1 | −7 | −276 | −0 | −0 | −100 | −120 |
| EBIT | −1 | 215 | 179 | 64 | 14 177 | 713 | −668 | −71 | −56 | −355 |
| Net financials | 1 | 1 | — | — | — | — | 19 | — | 280 | 332 |
| Profit before tax | 181 | 215 | 179 | 64 | 10 622 | 578 | −46 | −18 | 224 | 611 |
| Tax | −40 | −47 | −39 | −14 | −2 282 | −134 | −0 | −0 | −58 | −147 |
| Net profit | 141 | 168 | 140 | 50 | 8 340 | 444 | −46 | −18 | 166 | 464 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 094 | 1 307 | 1 395 | 1 482 | 15 516 | 14 133 | 13 554 | 13 246 | 13 367 | 13 212 |
| Equity | 1 056 | 1 224 | 1 364 | 1 413 | 9 754 | 10 198 | 10 152 | 10 134 | 10 300 | 10 764 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 38 | 83 | 31 | 68 | 2 208 | 244 | 315 | 78 | 33 | 48 |
| Total debt | 38 | 83 | 31 | 68 | 2 208 | 244 | 315 | 78 | 33 | 48 |
EBITDA margin
-23500000.0%
This company
15.8%
Market median
-148734277% vs market
20152024
Equity ratio
81.5%
This company
38.2%
Market median
+113% vs market
20152024
Return on equity
4.3%
This company
18.4%
Market median
-77% vs market
20152024
Net profit margin
46400000.0%
This company
8.1%
Market median
+572839406% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 2025 | — | — | |
ÅS Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Igelösa Life Science Aktiebolag | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Igelösa Life Science Aktiebolag
SICCONA AB Board members of SICCONA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birger Ola Mattias Kristensson | Audit | 0 companies |
| Ådne Steen | Chief Executive Officer | 0 companies |
| Axel Nils Gabriel Gyllenkrok | Chairman | 0 companies |
| Thomas Buchar | Chairman | 0 companies |
| Johan Tomas Ahlgren | Deputy Board Member | 0 companies |
| Stig Joar Steen | Deputy Board Member | 0 companies |